🇺🇸 opioid pain pills in United States
4 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 4
Most-reported reactions
- Contraindicated Product Administered — 1 report (25%)
- Nausea — 1 report (25%)
- Restless Legs Syndrome — 1 report (25%)
- Vomiting — 1 report (25%)
Other Pain Management approved in United States
Frequently asked questions
Is opioid pain pills approved in United States?
opioid pain pills does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for opioid pain pills in United States?
Rush University Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.